US FDA Assesses Over 500 Biopharma Plants Remotely Via Records Review; Refines Process

 
• By Bowman Cox

Agency may share outcomes of remote record reviews in lieu of inspections at US and foreign facilities.

production line
records in lieu of inspections working for fda for now

More from Manufacturing

More from Compliance